V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10285735 | 10073623 | null | null | null | 2019-12-27 | 2019-12-27 | IDELALISIB | 99 | null | PENTOSTATIN | 100919886 |
| 10407907 | 10073625 | 1.65 | 66 | null | 2020-09-08 | 2020-09-09 | null | 02 | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100734335 |
| 10330421 | 10073628 | 1.75 | 86 | null | 2021-10-18 | 2021-11-08 | Bexarotene | 02 | null | DOCETAXEL + GEMCITABINE | 100171223 |
| 10476349 | 10073641 | 1.62 | 71.7 | null | 2021-10-21 | 2021-10-25 | Docetaxel 75mg/m2 (21 day) | N | null | DOCETAXEL | 100795698 |
| 10478018 | 10073642 | 1.74 | 59.7 | null | 2020-06-25 | 2020-07-24 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101065849 |
| 10478666 | 10073643 | 1.77 | 75.4 | Palliative (P) | 2020-03-21 | 2020-06-07 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100445526 |
| 10480995 | 10073644 | 1.78 | 59.5 | null | 2021-01-17 | 2021-08-30 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101534738 |
| 10214003 | 10073647 | 1.65 | 75.2 | null | 2022-01-12 | 2022-02-19 | Enzalutamide | 02 | null | ENZALUTAMIDE | 101153356 |
| 10241543 | 10073648 | 1.58 | 130.4 | null | 2021-02-19 | 2021-02-19 | Capecitabine | 02 | null | CAPECITABINE | 100279137 |
| 10246813 | 10073649 | 1.55 | 90 | null | 2018-05-24 | 2018-07-22 | Capecitabine | 01 | null | TRIAL UNSPECIFIED | 101236487 |
| 10260903 | 10073654 | 0 | 74.5 | 03 | 2018-08-25 | 2018-09-08 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 101188771 |
| 10264477 | 10073655 | 1.71 | 93.8 | 03 | 2018-06-04 | 2018-06-10 | Venetoclax | 02 | N | VENETOCLAX | 100645930 |
| 10270563 | 10073656 | 1.75 | 87.6 | 03 | 2017-03-23 | 2017-04-21 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101157955 |
| 10279408 | 10073658 | 1.74 | 56 | null | 2016-07-09 | 2016-10-22 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100876226 |
| 10302956 | 10073659 | 1.79 | 87.6 | null | 2016-09-13 | 2017-10-10 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100553597 |
| 10304944 | 10073660 | 1.65 | 80.3 | null | 2020-11-06 | 2020-11-28 | Avelumab | 02 | null | CEMIPLIMAB | 101676107 |
| 10307515 | 10073661 | 1.69 | 74 | Adjuvant (A) | 2022-04-30 | 2022-04-30 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100495763 |
| 10314302 | 10073662 | 0 | 48.25 | null | 2022-02-08 | 2022-02-09 | Avelumab | 02 | null | FLUOROURACIL + IRINOTECAN | 101500828 |
| 10318813 | 10073663 | 1.5 | 0 | null | 2022-03-25 | 2022-04-14 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100441879 |
| 10323152 | 10073665 | 1.55 | 61.6 | null | 2019-04-05 | 2019-06-21 | null | 02 | null | RADIUM 223 | 100164694 |
| 10329035 | 10073666 | 1.6 | 76.05 | Palliative (P) | 2019-12-25 | 2020-01-25 | IMATINIB | 02 | N | IMATINIB | 100904689 |
| 10354581 | 10073668 | 1.85 | 0 | Palliative (P) | 2021-10-09 | 2021-10-10 | BCG Intravesical | 02 | N | BACILLUS CALMETTE-GUERIN | 100820369 |
| 10355560 | 10073669 | 1.68 | 80.9 | Curative (C) | 2022-04-15 | 2022-04-30 | null | 02 | N | ATEZOLIZUMAB | 101498072 |
| 10393881 | 10073672 | 1.83 | 66.3 | null | 2018-12-09 | 2019-03-04 | CABOZANTINIB | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101109475 |
| 10409542 | 10073674 | 1.8 | 74.1 | Palliative (P) | 2022-05-03 | 2022-05-10 | Cabazitaxel | 02 | N | CABAZITAXEL | 100586671 |
| 10415900 | 10073675 | 1.83 | 60 | Palliative (P) | 2005-02-04 | 2020-05-29 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101412971 |
| 10444165 | 10073679 | null | null | null | 2019-10-26 | 2019-10-26 | MUK 8 TRIAL | 02 | null | BENDAMUSTINE | 100926689 |
| 10457185 | 10073680 | 1.65 | 100 | Curative (C) | 2018-11-25 | 2018-11-25 | Zanubrutinib | 02 | N | CARFILZOMIB | 101304930 |
| 10468857 | 10073681 | 1.72 | 81.9 | null | 2020-03-31 | 2020-03-31 | null | 02 | null | CAPECITABINE + CISPLATIN | 101815249 |
| 10285735 | 10073683 | 1.68 | 78.4 | null | 2016-04-22 | 2019-12-22 | null | 02 | null | OBINUTUZUMAB | 100919886 |
| 10407907 | 10073684 | 1.58 | 101 | Curative (C) | 2020-08-21 | 2020-09-23 | null | 02 | N | TRABECTEDIN | 100734335 |
| 10330421 | 10073686 | 1.7 | 61.8 | null | 2021-12-06 | 2021-12-06 | CRIZOTINIB | 02 | null | CYTARABINE HIGH DOSE | 100171223 |
| 10476349 | 10073692 | null | null | null | 2021-10-28 | 2021-11-05 | Enzalutamide | 02 | null | ENZALUTAMIDE | 100795698 |
| 10214003 | 10073694 | null | null | null | 2022-01-29 | 2022-03-09 | Enzalutamide | 02 | null | ENZALUTAMIDE | 101153356 |
| 10246813 | 10073695 | 0.01 | 87.6 | Palliative (P) | null | 2018-04-24 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101236487 |
| 10302956 | 10073703 | 1.55 | null | null | 2016-12-07 | 2017-11-05 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100553597 |
| 10314302 | 10073705 | 1.69 | 90.2 | Curative (C) | 2020-10-16 | 2022-03-10 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101500828 |
| 10318813 | 10073706 | 1.63 | 45.8 | null | 2021-01-02 | 2022-04-14 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100441879 |
| 10329035 | 10073707 | 1.71 | 66.4 | null | 2019-05-20 | 2020-02-19 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100904689 |
| 10354581 | 10073709 | 1.63 | 67.4 | Unknown (U) | 2021-10-03 | 2021-11-17 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100820369 |
| 10393881 | 10073711 | 1.66 | 159 | 03 | null | 2019-02-10 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101109475 |
| 10444165 | 10073716 | 1.79 | 50.5 | 03 | 2019-10-24 | 2019-11-16 | DABRAFENIB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100926689 |
| 10280266 | 10073717 | 0 | 90.1 | null | null | 2019-07-09 | null | 02 | null | MITOMYCIN INTRAVESICULAR | 100528963 |
| 10407907 | 10073719 | null | 72.5 | null | null | 2020-10-23 | Tivozanib | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100734335 |
| 10330421 | 10073721 | 1.67 | 47.3 | 03 | null | 2022-01-02 | null | 02 | null | PERTUZUMAB | 100171223 |
| 10264477 | 10073730 | 1.73 | 85 | null | 2018-01-25 | 2018-07-21 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100645930 |
| 10270563 | 10073731 | 1.68 | 70.3 | null | 2016-11-12 | 2017-05-04 | LENALIDOMIDE | 02 | null | LENALIDOMIDE | 101157955 |
| 10314302 | 10073734 | 1.77 | 71.8 | null | 2022-02-09 | 2022-03-21 | Venetoclax | 02 | null | FLUOROURACIL + IRINOTECAN | 101500828 |
| 10354581 | 10073736 | 1.66 | 83.7 | null | 2022-01-14 | 2022-01-14 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100820369 |
| 10280266 | 10073742 | 1.51 | 67.8 | null | 2019-05-16 | 2019-06-13 | null | 02 | N | OBINUTUZUMAB | 100528963 |